Anzeige
Mehr »
Login
Donnerstag, 30.01.2025 Börsentäglich über 12.000 News von 684 internationalen Medien
Absoluter Geheimtipp: Vergessen Sie Gold, Silber und Uran!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
263 Leser
Artikel bewerten:
(1)

Erectile Dysfunction Drugs Market size worth $ 2952 Million, Globally, by 2028 at -3.4% CAGR: Verified Market Research

Finanznachrichten News

Growing patient awareness and education levels and increasing of geriatric population. Increasing adoption of a sedentary lifestyle and rising incidence of lifestyle diseases are driving the market growth of the Erectile Dysfunction Drugs Market.

Jersey City, N.J., Feb. 11, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Erectile Dysfunction Drugs Market" By Drug Type (Viagra (Sildenafil Citrate), Levitra/Staxyn (Vardenafil), Cialis (Tadalafil), Zydena (Udenafil)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales), and By Geography. According to Verified Market Research, the Global Erectile Dysfunction Drugs Market size was valued at USD 3629 Million in 2020 and is projected to reach USD 2952 Million by 2028, de-growing at a CAGR of -3.4% from 2021 to 2028.

Verified_Market_Research_Logo

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=180105

Browse in-depth TOC on "Erectile Dysfunction Drugs Market"

202 - Pages

126 - Tables

37 - Figures

Global Erectile Dysfunction Drugs Market Overview

The increasing adoption of a sedentary lifestyle and the rising incidence of lifestyle diseases are essential factors boosting the growth and demand of the Erectile Dysfunction Drugs Market: the growing geriatric population and patient awareness and education levels. Again, the various government reforms and general awareness initiatives in growing regions also improve the market's growth. The increasing manufacturers of generic drugs with a rising sedentary lifestyle and corresponding anxiety also raise market growth.

The growing number of men suffering from this disorder and the patent expiry of many blockbuster drugs increase the development of the Erectile Dysfunction Drugs Market. The increasing investments in research and development for new drugs and clinical testing are the factors of expanding the Erectile Dysfunction Drugs Market. Yet, the poor patient compliance to erectile dysfunction drugs and availability of cost-effective imitation medicines will restrain the growth of the Erectile Dysfunction Drugs Market. At the same time, the various side effects of the drug can oppugn the Erectile Dysfunction Drugs Market.

Key Developments in Erectile Dysfunction Drugs Market

  • On June 2020, Launch Medical and GAINSWave announced the resolution of their lawsuit. They started working together to market their revolutionary home-use acoustic wave device called The Phoenix to treat erectile dysfunction.
  • On December 2020, Glenmark Pharma received the final approval from the US health regulator for Tadalafil tablets, used to treat erectile dysfunction and enlarged prostate.

Key Players

The major players in the market are Apricus Biosciences Inc., Bayer AG, Eli Lilly and Company, Ferring Pharmaceuticals, GlaxoSmithKline PLC, Metuchen Pharmaceuticals LLC, Pfizer Inc., S.K. Chemicals Co. Ltd, Teva Pharmaceutical Industries Ltd, and VIVUS Inc.

Verified Market Research has segmented the Global Erectile Dysfunction Drugs Market On the basis of Drug Type, Distribution Channel, and Geography.

  • Erectile Dysfunction Drugs Market, By Drug Type
    • Viagra (Sildenafil Citrate)
    • Levitra/Staxyn (Vardenafil)
    • Cialis (Tadalafil)
    • Zydena (Udenafil)
    • Helleva (Lodenafil Carbonate)
    • Avanafil (Stendra/ Spedra)
    • Mvix (Mirodenafil)
    • Others
  • Erectile Dysfunction Drugs Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Sales
    • Others
  • Erectile Dysfunction Drugs Market by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Sex Toys Market By Type (Erection Rings, Adult Vibrators, Dildos), By Application (Retail stores, Specialty stores, Online stores), By Geography, Forecast, 2020-2027

Plaque Modification Devices Market By Type (Atherectomy devices, Thrombectomy devices, Chronic total occlusion devices), By Application (Coronary artery diseases, Peripheral artery diseases, Neurovascular diseases), By End-User (Hospitals, Specialty Clinics, and Ambulatory surgical centers) By Geography, Forecast, 2020-2027

Atherectomy Devices Market By Product (Directional Atherectomy Systems, Orbital Atherectomy Systems, Photo-Ablative (Laser) Atherectomy Systems), By Application (Peripheral Vascular, Cardiovascular, Neurovascular), By End-User (Hospitals & Surgical Centers, Research Laboratories & Academic Institutes, Ambulatory Care Centers), By Geography, Forecast, 2020-2027

Sex Reassignment Surgery Market By Gender Transition Type (Male to Female and Female to Male), By Geography, Forecast, 2020-2027

Top 9 Breast Implant Manufacturers: Leading visionaries in cosmetic surgeries

Visualize Erectile Dysfunction Drugs Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us
Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

© 2022 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.